NeuroPace, Inc. (NPCE)

NASDAQ: NPCE · Real-Time Price · USD

13.83

-0.32 (-2.26%)

At close: Mar 3, 2026, 4:00 PM EST

14.03

+0.20 (1.45%)

Pre-market: Mar 4, 2026, 6:26 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Products		79.91M	65.42M	45.52M	45.18M	41.14M
Medical Products Growth		22.14%	43.72%	0.75%	9.83%	11.27%
Total		79.91M	65.42M	45.52M	45.18M	41.14M
Total Growth		22.14%	43.72%	0.75%	9.83%	11.27%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States		79.91M	65.42M	45.52M	45.18M	41.14M
United States Growth		22.14%	43.72%	0.75%	9.83%	11.27%
Total		79.91M	65.42M	45.52M	45.18M	41.14M
Total Growth		22.14%	43.72%	0.75%	9.83%	11.27%

Source: S&P Global Market Intelligence.